|
2025
|
P/S
|
Pharmaceutical preparations for the treatment of oncological and immune system related diseases a... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of oncological
and immune system related diseases ... |
|
|
P/S
|
Providing information about medical and scientific research. Providing medical information; provi... |
|
|
Invention
|
Methods of treating a ras related disease or disorder.
The disclosure features methods of treati... |
|
|
Invention
|
Ras inhibitors. The disclosure features macrocyclic compounds, and pharmaceutical compositions an... |
|
|
Invention
|
Compounds, complexes, and methods for their preparation and of their use.
The invention features... |
|
|
Invention
|
Methods for predicting response to a ras inhibitor therapy and combination therapies. The present... |
|
|
Invention
|
Ras inhibitors.
The disclosure features macrocyclic compounds, and pharmaceutical compositions a... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of
oncological, neurological, immunological, and g... |
|
|
Invention
|
Methods for predicting response to a ras(on) inhibitor and combination therapies. The present dis... |
|
|
Invention
|
Peptide conjugates. Disclosed herein are peptide conjugates formed by covalently linking a peptid... |
|
|
P/S
|
Pharmaceutical research and development; Drug discovery services; Providing information about med... |
|
|
P/S
|
Providing information about medical and scientific research Providing medical information; Provid... |
|
2024
|
P/S
|
Pharmaceutical preparations for the treatment of oncological, neurological, immunological, and ge... |
|
|
Invention
|
Ras inhibitors.
The invention features macrocyclic compounds, and pharmaceutical compositions an... |
|
|
P/S
|
Providing medical research information about oncological and immune system related diseases and d... |
|
|
Invention
|
Macrocyclic ras inhibitors. The disclosure features macrocyclic compounds, and pharmaceutical com... |
|
|
Invention
|
Synthesis of ras inhibitors.
The present invention relates to Ras inhibitors, intermediates in t... |
|
|
Invention
|
Synthesis of ras inhibitors. The present invention relates to Ras inhibitors, intermediates in th... |
|
|
Invention
|
Methods of treating cancer with an mtor inhibitor.
The present disclosure relates to methods for... |
|
|
Invention
|
Methods for treating immune refractory lung cancer.
The disclosure features methods for treating... |
|
|
Invention
|
Methods of treating a ras protein-related disease or disorder.
The disclosure features methods o... |
|
|
Invention
|
Rmc-6291 for use in the treatment of ras protein-related disease or disorder. The disclosure feat... |
|
|
Invention
|
Compounds that participate in cooperative binding and uses thereof.
The invention features compo... |
|
|
Invention
|
Methods of treating a ras related disease or disorder. The disclosure features methods of treatin... |
|
|
P/S
|
Providing medical research information about pancreatic cancer and clinical trials for a clinical... |
|
|
Invention
|
Shp2 inhibitor compositions and methods for treating cancer.
The present invention is directed t... |
|
|
Invention
|
Combination therapy for a ras related disease or disorder. The present disclosure relates to comb... |
|
|
Invention
|
C40-, c28-, and c-32-linked rapamycin analogs as mtor inhibitors.
The present disclosure relates... |
|
|
Invention
|
Identifying new therapeutic agents.
Disclosed herein are methods for identifying novel drug cand... |
|
|
Invention
|
Synthesis of ras inhibitors.
The present invention relates to Ras inhibitors and to methods for ... |
|
|
Invention
|
Crystalline forms of ras inhibitors, compositions containing the same, and methods of use thereof... |
|
|
Invention
|
Crystalline forms of a ras inhibitor. The disclosure features crystalline forms of Ras inhibitors... |
|
|
Invention
|
Synthesis of ras inhibitors. The present invention relates to Ras inhibitors and to methods for p... |
|
|
Invention
|
Methods and reagents for analyzing protein-protein interfaces.
The present disclosure provides m... |
|
2022
|
Invention
|
Pyrazolopyrazine compounds as shp2 inhibitors.
Provided herein are compounds and pharmaceutical ... |
|
|
Invention
|
Use of sos1 inhibitors with mtor inhibitors to treat cancers.
The present disclosure relates to ... |
|
2021
|
Invention
|
Use of sos1 inhibitors to treat malignancies with shp2 mutations.
Methods are provided herein fo... |
